New to this board and stop. I bought in today based on Schwab's B rating. Did a bit of DD and it looks like a promising stock. Appreciate input on when and what type of news should I be watching by year end 2013. Thanks
Z160 is the next big thing for Zalicus. So, buying in now is smart, this is the next promising drug in the pipeline along with Z944. Zalicus has enough money right now to last them through 2014 and keep in mind we will most likely see a R/S by October of this year but it's needed to get over $1 thus allowing big institutional buyers.